How much does a box of Ivosidenib cost?

Ivosidenib (Ivosidenib) is a new type of targeted therapy drug, mainly used to treat patients with acute myeloid leukemia (AML) who express IDH1 gene mutations. AML is a subtype of leukemia caused by the abnormal proliferation of malignant clonal cells in the bone marrow, and mutations in the IDH1 gene are one of the specific genetic abnormalities.

Avosidenib is already on the market in China, but it has not yet been included in medical insurance. The price of Avosidenib on the domestic market is very high, reaching tens of thousands of yuan. For specific prices, please consult the local hospital pharmacy. The price of the American original drug of Ivonib abroad is as high as hundreds of thousands. Currently, there are generic drugs of Ivonib on the market, mainly Laos generic drugs, which cost about 10,000 yuan, which is much cheaper in comparison, and the ingredients of the original drug and the generic drug are basically the same.

Avosidenib belongs to the drug classIDH1inhibitors. IDH1 is an enzyme involved in cell metabolism. In some AML patients, the IDH1 gene is mutated, leading to abnormal activation of the enzyme. What is unique about ivosidenib is its ability to inhibit this abnormal activation, thereby regulating the metabolic process of leukemia cells.

By specifically interfering with the function ofIDH1 enzyme, ivonib is expected to slow down or prevent the growth and proliferation of leukemia cells, thereby improving the patient's condition. This targeted therapy strategy is more precise than traditional chemotherapy, and is expected to improve the effectiveness of treatment and reduce damage to normal cells.

When using ivonib, doctors usually develop a personalized treatment plan based on the patient's specific situation and conduct regular monitoring to evaluate the drug's efficacy and patient safety. While ivonib is approved for use in AML, researchers are also exploring its potential in other cancer types, including some solid tumors.